Molbio Diagnostics Ltd (MOLBIO) — Announcement | 9 September 2026

· BSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company updates CIN number post-listing
🔄 What Changed
CIN format changed from U... to L... and status updated to Listed
💡 Investor Takeaway
This confirms the company is now officially listed with a new CIN format, validating its public market status.

Molbio Diagnostics Ltd announced a change to its Corporate Identification Number (CIN) from U33125GA2000PLC002909 to L33125GA2000PLC002909 following its stock exchange listing on August 17, 2026. The Ministry of Corporate Affairs updated the company's status from Unlisted to Listed, reflecting its new public company designation. This administrative change confirms its transition to a listed entity under the new CIN format.

📄 View Original Announcement (PDF)

About Molbio Diagnostics Ltd (MOLBIO)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹16,255.48 Cr

View full MOLBIO stock details →

📡 Get AI alerts when MOLBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MOLBIO — Free

📊 More MOLBIO filings

See all MOLBIO filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MOLBIO files new disclosures

Track MOLBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MOLBIO — Free

Free account · 2 AI queries/day